Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Formula: C54H57N5O10
5-dioxopyrrolidin-1-yl)oxy]carbonyl}phenyl)-3
120 and 240 min after drug administration in plasma and brain samples
6-trihydroxy-8-(3-hydroxy-3-methylbutyl)-7-methoxy-2-(3-methylbut-2-en-1-yl)-9H-xanthen-9-one
first Glibenclamide (1 mg/kg/15 min) and then U-89232 (3 mg/kg/15 min) are infused before the 60 min of ischemia
(1S, 2S)-Bortezomib Size:Contact [email protected] for quotation Formula: C54H57N5O10(1S,2S) Bortezomib is an enantiomer of Bortezomib. Bortezomib is a cell permeable, reversible, and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki of 0. 6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF B. Bortezomib is an anti cancer agent and the first therapeutic proteasome inhibitor to be used in humans. Product information CAS Number: 1132709 14 8 Molecular